Canagliflozin/teneligliptinAlternative Names: MT-2412; TA-7284/MP-513; Teneligliptin/canagliflozin
Latest Information Update: 29 Aug 2016
At a glance
- Originator Mitsubishi Tanabe Pharma Corporation
- Class Antihyperglycaemics; Glucosides; Ketones; Piperazines; Pyrazoles; Small molecules; Thiazolidines; Thiophenes
- Mechanism of Action CD26 antigen inhibitors; Sodium-glucose transporter 2 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Type 2 diabetes mellitus